The latest quarterly earnings report for Waters Corporation is scheduled for Monday, May 4th, with a consensus estimate EPS of 2.31.
Waters Corporation is currently priced at $300.07, experiencing a price change of 28 cents (0.093%) since the previous close. The trading volume is at $267,325, representing a 22% deviation from the average.
Waters Corporation has been on a five-day streak, with a price decrease of $-35.54 (-10.59%) since the streak began at $335.61.
The most recent earnings report for Waters Corporation was on Wednesday, February 11th, with a consensus estimate EPS of 4.5.
The company's cash flow indicates a positive trend with a net change in cash of $128.71 million, ending the period with $587.83 million in cash.
Waters Corporation's revenue stands at $932.36 million, generating a gross profit of $557.42 million. The net income reported is $225.21 million, translating to an EPS of $3.78.
Key financial ratios for Waters Corporation include a net profit margin of 24.16%, return on equity of 8.79%, and a price-to-earnings ratio of 25.11.
The balance sheet reveals total assets of $5 billion, with cash and cash equivalents amounting to $587.83 million and total liabilities at $2.52 billion.
This comprehensive financial analysis showcases Waters Corporation's solid performance amidst market challenges.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.